Induction Healthcare Group PLC Block listing Interim Review (7796H)

TIDMINHC

RNS Number : 7796H

Induction Healthcare Group PLC

31 July 2023

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

Block Listing Six Monthly Return

Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems, makes the six monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies below. The Company has identified an error in the six monthly update to 26 July 2022, announced on 27 July 2022, which incorrectly detailed 396,567 ordinary shares as having been issued and allotted when it should have been 329,573 ordinary shares. As such, the number of ordinary shares still to be issued and allotted is 3,170,427 and not 3,103,433 as previously incorrectly disclosed.

 
 Name of applicant:                               Induction Healthcare Group PLC 
 
                                                   LEI: 213800RY96GCZQW5TP19 
 Name of scheme:                                  The Induction Healthcare NTA Share 
                                                   Option Plan 
                                                 ------------------------------------------- 
 Period of return:                                 From:    27/01/2023    To:     26/07/2023 
                                                 --------  ------------  ------  ----------- 
 Number and class of securities                   3,500,000 ordinary shares on 26 July 
  originally admitted and the date                 2021 
  of admission 
                                                 ------------------------------------------- 
 Balance of unallotted securities 
  under scheme(s) from initial 
  application:                                    3,170,427 
                                                 ------------------------------------------- 
 Plus: The amount by which the                    Nil 
  block scheme(s) has been increased 
  since the date of the last return 
  (if any increase has been applied 
  for): 
                                                 ------------------------------------------- 
 Less: Number of securities issued/allotted       Nil 
  under scheme(s) during the period: 
                                                 ------------------------------------------- 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at end 
  of period:                                      3,170,427 
                                                 ------------------------------------------- 
 Contact:                                         Louise Torr, Company Secretary 
                                                   [e-mail] 
                                                 ------------------------------------------- 
 
 
 

Enquiries

 
 Induction 
  Christopher Samler, Chair                 [phone] 
  Paul Tambeau, Chief Executive Officer      [phone] 
 
 Singer Capital Markets (Nominated 
  Adviser and Broker)                      [phone] 
 Philip Davies 
 

About Induction - www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions that transforms care delivery and the patient journey through hospital. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRWPUBUMUPWGCG

(END) Dow Jones Newswires

July 31, 2023 10:13 ET (14:13 GMT)